“HeartMate 3 LVAD as Destination Therapy can change Concept of Advanced Heart Failure Management: A Systematic Review and Meta Analysis in terms of Survival benefits and limitations” (2025) Vascular and Endovascular Review, 8(16s), pp. 79–93. doi:10.64149/J.Ver.8.16s.79-93.